Your browser doesn't support javascript.
[Risk of myocarditis associated with mRNA vaccines for prevention of COVID-19]. / Myokarditisrisiko bei mRNA-Impfstoffen zur Prävention von COVID-19.
Augustin, M; Hallek, M; Nitschmann, S.
  • Augustin M; Klinik I für Innere Medizin, Universitätsklinikum Köln (AöR), Kerpener Str. 62, 50937, Köln, Deutschland. max.augustin@uk-koeln.de.
  • Hallek M; Klinik I für Innere Medizin, Universitätsklinikum Köln (AöR), Kerpener Str. 62, 50937, Köln, Deutschland.
  • Nitschmann S; , Lippetal, Deutschland.
Internist (Berl) ; 63(4): 461-464, 2022 04.
Article in German | MEDLINE | ID: covidwho-1733960

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Myocarditis Type of study: Diagnostic study / Prognostic study Topics: Vaccines Limits: Humans Language: German Journal: Internist (Berl) Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Myocarditis Type of study: Diagnostic study / Prognostic study Topics: Vaccines Limits: Humans Language: German Journal: Internist (Berl) Year: 2022 Document Type: Article